O-(2-Oxopyrrolidin-5-yl)trichloroacetimidates as Amidoalkylating Agents
FULL PAPER
(s, 3 H, Ac.), 2.15 (s, 3 H, Ac.), 2.25 (dd, J ϭ 5.2, 14.7 Hz, 1 H,
CHCH2CHϭCH2), 2.40 (dd, J ϭ 7.8, 14.0 Hz, 1 H, CHCH2CHϭ
CH2), 3.49 (dd, J ϭ 7.7, 15.2 Hz, 1 H, NCH2CHϭCH2), 3.99 (ddd,
Ph-H), 6.43 (d, J ϭ 2.4 Hz, 1 H, Ph-H) ppm. 13C NMR (CDCl3,
62.8 MHz): δ ϭ 20.6, 20.7, 27.4, 55.3, 55.4, 60.4, 63.3, 74.8, 75.0,
98.4, 106.0, 114.1, 142.0, 159.7, 160.9, 168.1, 170.0, 170.4 ppm. EI-
J ϭ 4.4, 8.0, 9.8 Hz, 1 H, 5-H), 4.42 (dd, J ϭ 4.6, 15.2 Hz, 1 H, FAB: m/z (%) ϭ 351 (10) [Mϩ Ϫ CHO], 291 (35), 249 (100), 232
NCH2CHϭCH2), 5.15Ϫ5.25 (m,
4
H, CHCH2CHϭCH2, (30), 180 (45), 149 (35), 91 (20), 77 (25). C18H23NO8 (381.4): calcd.
NCH2CHϭCH2), 5.37 (dd, J ϭ 8.0, 8.1 Hz, 1 H, 4-H), 5.61 (d,
J ϭ 8.1 Hz, 1 H, 3-H) 5.69 (m, 2 H, CHCH2CHϭCH2, NCH2CHϭ
CH2) ppm. 13C NMR (CDCl3, 150.9 MHz): δ ϭ 20.7, 32.4, 43.9,
55.3, 72.7, 73.2, 119.4, 119.9, 131.2, 132.4, 166.4, 169.9, 170.3 ppm.
EI-FAB: m/z (%) ϭ 281 (10) [Mϩ], 240 (35), 181 (48), 138 (100),
55 (20). C14H19NO5 (281.3): calcd. C 59.78, H 6.81, N 4.98; found
C 60.03, H 6.96, N 4.55.
C 56.68, H 6.08, N 3.67; found C 56.69, H 6.51, N 3.92.
General Procedure for Olefin Metathesis
Synthesis of Dehydroindolizinones 11 and 12: A solution of
{bis(tricyclohexylphosphane)benzylidene}ruthenium(IV)
dichloride (Grubbs’) catalyst (0.003 g, 0.004 mmol) in CH2Cl2
(5 mL) was added to a solution of 2b or 7b (281 mg, 1 mmol) in
CH2Cl2 (10 mL), under an argon atmosphere. The mixture was re-
fluxed for 12 h. The solvent was removed under reduced pressure
and the oily residue was purified by column chromatography on
silica gel (petroleum ether/ethyl acetate, 5:1) to give dehydroindoliz-
inones 11 or 12, respectively.
7b: Column chromatography on silica gel (petroleum ether/ethyl
acetate, 1:1) afforded 7b as a colorless oil (yield 170 mg, 48%).
[α]D ϭ ϩ177 (c ϭ 1.0, MeOH). 1H NMR (CDCl3, 600 MHz): δ ϭ
2.07 (s, 3 H, Ac.), 2.13 (s, 3 H, Ac.), 2.37 (dd, J ϭ 7.2, 14.3 Hz, 1 H,
CHCH2CHϭCH2), 2.51 (m, 1 H, CHCH2CHϭCH2), 3.51 (dd, J ϭ
7.5, 15.5 Hz, 1 H, NCH2CHϭCH2), 3.60 (ddd, J ϭ 3.4, 5.0, 8.5 Hz,
1 H, 5-H), 4.42 (dd, J ϭ 4.5, 15.5 Hz, 1 H, NCH2CHϭCH2), 5.14
(dd, J ϭ 5.0, 5.0 Hz, 1 H, 4-H), 5.18Ϫ5.23 (m, 4 H, CHCH2CHϭ
CH2, NCH2CHϭCH2), 5.38 (d, J ϭ 5.0 Hz, 1 H, 3-H), 5.67 (m,
2 H, CHCH2CHϭCH2, NCH2CHϭCH2) ppm. 13C NMR (CDCl3,
150.9 MHz): δ ϭ 20.7, 20.8, 34.8, 43.1, 58.6, 74.4, 118.9, 119.9,
131.1, 131.4, 167.3, 169.9 ppm. EI-FAB: m/z (%) ϭ 281 (10) [Mϩ],
240 (32), 181 (50), 138 (100), 55 (20). C14H19NO5 (281.3): calcd. C
59.78, H 6.81, N 4.98; found C 59.38, H 6.78, N 4.78.
(1S,2R,8aS)-1,2-Diacetyloxy-1,2,3,5,8,8a-hexahydro-3-indolizinone
(11): Colorless oil (196 mg, 78%). [α]D ϭ ϩ26.2 (c ϭ 0.9, MeOH).
1H NMR (CDCl3, 600 MHz): δ ϭ 2.05 (m, 1 H, 8-H), 2.15 (s, 3 H,
Ac.), 2.17 (s, 3 H, Ac.), 2.22 (m, 1 H, 8-H), 3.61 (br d, J ϭ 18.4 Hz,
1 H, 5-H), 4.02 (ddd, J ϭ 4.4, 7.3, 11.4 Hz, 1 H, 8a-H), 4.39 (dd,
J ϭ 2.4, 18.8 Hz, 1 H, 5-H), 5.45 (dd, J ϭ 7.3, 6.6 Hz, 1 H, 1-H),
5.48 (d, J ϭ 7.3 Hz, 1 H, 2-H), 5.71 (dd, J ϭ 3.0, 10.3 Hz, 1 H, 6-
H), 5.83 (m, 1 H, 7-H) ppm. 13C NMR (CDCl3, 150.9 MHz): δ ϭ
20.7, 30.4, 40.6, 65.6, 74.8, 78.1, 122.6, 123.8, 166.4, 169.9, 170.3
ppm.
(3R,4S)-4-(Acetyloxy)-5-(4-methoxyphenyl)-1-methyl-2-oxo-
pyrrolidin-3-yl Acetate (8): Column chromatography on silica gel
(petroleum ether/ethyl acetate, 1:1) afforded 8 as a colorless oil
(310 mg, 68%). [α]D ϭ Ϫ21.68 (c ϭ 1.9, MeOH). 1H NMR (CDCl3,
250 MHz): δ ϭ 2.02 (s, 3 H, Ac.), 2.10 (s, 3 H, Ac.), 2.61 (s, 3 H,
NCH3), 3.79 (s, 6 H, OCH3), 4.69 (d, J ϭ 5.0 Hz, 1 H, 5-H), 5.40
(dd, J ϭ 5.0, 4.9 Hz, 1 H, 4-H), 5.48 (d, J ϭ 5.0, 1 H, 3-H),
6.90Ϫ7.30 (m, 4 H, Ph-H) ppm. 13C NMR (CDCl3, 62.8 MHz):
δ ϭ 20.6, 27.9, 55.3, 62.2, 74.6, 76.5, 111.0, 114.4, 120.8, 123.6,
128.8, 130.2, 157.6, 167.8, 169.6, 169.8 ppm. EI-FAB: m/z (%) ϭ
321 (20) [Mϩ], 261 (55), 219 (100), 202 (20), 150 (40), 91 (20).
C16H19NO6 (321.3): calcd. C 59.81, H 5.96, N 4.35; found C 59.89,
H 6.29, N 4.33.
(1S,2R,8aR)-1,2-Diacetyloxy-1,2,3,5,8,8a-hexahydro-3-indolizinone
(12): Colorless oil (196 mg, 78%). [α]D ϭ ϩ17 (c ϭ 1, MeOH). H
1
NMR (CDCl3, 600 MHz): δ ϭ 2.13 (s, 3 H, Ac.), 2.15 (s, 3 H, Ac.),
2.20 (m, 1 H, 8-H), 2.55 (br d, J ϭ 16.8 Hz, 1 H, 8-H), 3.50 (dt,
J ϭ 5.0, 4.5 Hz, 1 H, 8a-H), 3.64 (br d, J ϭ 18.7 Hz, 1 H, 5-H),
4.34 (dd, J ϭ 2.4, 18.8 Hz, 1 H, 5-H), 5.07 (dd, J ϭ 5.0, 5.0 Hz,
1 H, 1-H), 5.45 (d, J ϭ 5.0 Hz, 1 H, 2-H), 5.72 (dd, J ϭ 2.6,
10.3 Hz, 1 H, 7-H), 5.82 (t, J ϭ 7.9 Hz, 1 H, 6-H) ppm. 13C NMR
(CDCl3, 150.9 MHz): δ ϭ 20.7, 20.9, 25.4, 40.9, 52.7, 73.1, 74.1,
123.8, 123.9, 167.3, 169.8 ppm. EI-FAB: m/z (%) ϭ 252 (40) [Mϩ
Ϫ 1], 211 (20), 193 (40), 151 (100), 134 (20), 82 (25). C12H15NO5
(253.2): calcd. C 56.91, H 5.97, N 5.53; found C 56.66, H 6.35,
N 5.23.
(3R,4S)-4-(Acetyloxy)-5-(2,4-dimethoxyphenyl)-1-methyl-2-oxo-
pyrrolidin-3-yl Acetate (9): Column chromatography on silica gel
(petroleum ether/ethyl acetate, 5:1) afforded 9 as a colorless oil
(yield 350 mg, 70%). [α]D ϭ Ϫ40.8 (c ϭ 1.0, MeOH). 1H NMR
(CDCl3, 250 MHz): δ ϭ 2.03 (s, 3 H, Ac.), 2.13 (s, 3 H, Ac.), 2.61
(s, 3 H, NCH3), 3.79 (s, 6 H, OCH3), 4.62 (d, J ϭ 5.0 Hz, 1 H, 5-
H), 5.42 (dd, J ϭ 5.0, 5.0 Hz, 1 H, 4-H), 5.49 (d, J ϭ 5.0, 1 H, 3-
H), 6.46 (m, 2 H, Ph-H), 7.04 (d, J ϭ 8.5 Hz, 1 H, Ph-H) ppm.
13C NMR (CDCl3, 62.8 MHz): δ ϭ 20.8, 28.0, 55.5, 55.6, 62.0,
74.9, 76.7, 99.1, 104.2, 104.9, 116.1, 130.1, 159.0, 162.0, 167.7,
169.9, 170.1 ppm. EI-FAB: m/z (%) ϭ 351 (7) [Mϩ], 291 (55), 249
(100), 232 (37), 180 (47), 149 (17). C17H21NO7 (351.3): calcd. C
58.11, H 6.02, N 3.99; found C 58.54, H 6.41, N 3.83.
(1S,2S,8aS)-(؊)-1,2-Dihydroxy-1,2,3,5,8,8a-hexahydroindolizine
(13): A solution of 11 (267 mg, 1.13 mmol) dissolved in THF
(10 mL) was added under argon to a suspension of LiAlH4 in THF
(0.088 g, 2.3 mmol in 5 mL) and heated at reflux for 4 h. Excess
hydride was destroyed at 0 °C with 10% aq. NH4Cl (0.3 mL), the
solid was filtered and washed with ethyl acetate (30 mL). The or-
ganic phase was dried (MgSO4) and after solvent evaporation, the
crude material was purified by column chromatography on silica
gel (CH2Cl2/MeOH, 10:1) to give 13 (yield 117 mg, 73%) as a white
1
solid, m.p. 92Ϫ93 °C. [α]D ϭ ϩ88.2 (c ϭ 2.4, MeOH). H NMR
(D2O, 600 MHz): δ ϭ 1.97 (m, 1 H, 8-H), 2.19 (dt, J ϭ 1.9, 4.0 Hz,
1 H, 8a-H), 2.26 (dd, J ϭ 4.2, 7.1 Hz, 1 H, 8-H), 2.60 (dd, J ϭ 7.5,
11.3 Hz, 1 H, 3-H), 2.71 (dt, J ϭ 2.2, 1.7 Hz, 1 H, 5-H), 2.88 (dd,
J ϭ 1.7, 11.3 Hz, 1 H, 3-H), 3.19 (ddt, J ϭ 2.2, 4.2, 2.2 Hz, 1 H,
5-H), 3.61 (dd, J ϭ 4.0, 8.1 Hz, 1 H, 1-H), 4.03 (ddd, J ϭ 1.8, 3.9,
7.4 Hz, 1 H, 2-H), 5.59 (dd, J ϭ 1.4, 10.1 Hz, 1 H, 6-H), 5.68 (m,
1 H, 7-H) ppm. 13C NMR (CDCl3, 150.9 MHz): δ ϭ 28.2, 51.3,
63.3, 74.9, 83.1, 123.8, 124.1 ppm. EI-FAB: m/z (%) ϭ 155 (40)
[Mϩ], 95 (100), 82 (35), 67 (65), 54 (45). C8H13NO2 (155.2): calcd.
C 61.91, H 8.44, N 9.02; found C 61.69, H 8.54, N 8.62.
(3R,4S)-4-(Acetyloxy)-5-(6-hydroxymethyl-2,4-dimethoxyphenyl)-1-
methyl-2-oxopyrrolidin-3-yl Acetate (10): Column chromatography
on silica gel (petroleum ether/ethyl acetate, 1:1) afforded 10 as a
colorless oil (yield 350 mg, 65%). [α]D ϭ Ϫ15.9 (c ϭ 2.2, MeOH).
1H NMR (CDCl3, 250 MHz): δ ϭ 1.97 (s, 3 H, Ac.), 2.10 (s, 3 H,
Ac.), 2.40 (br s, 1 H, OH), 2.48 (s, 3 H, NCH3), 3.72 (s, 3 H,
OCH3), 3.73 (s, 3 H, OCH3), 4.54 (2d, J ϭ 12.0 Hz, 2 H, CH2OH),
4.82 (d, J ϭ 4.6 Hz, 1 H, 5-H), 5.45 (dd, J ϭ 4.6, 4.6 Hz, 1 H, 4-
H), 5.58 (d, J ϭ 4.6 Hz, 1 H, 3-H), 6.36 (d, J ϭ 2.4 Hz, 1 H,
(1S,2S,8aR)-(؊)-1,2-Dihydroxy-1,2,3,5,8,8a-hexahydroindolizine
(14): Preparation was performed from 12 as described for 13 fur-
Eur. J. Org. Chem. 2002, 4137Ϫ4142
4141